Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

The Lancet

Volumn 344, Issue 8922, 1994, Pages 563-570

  Yusuf, S ^a,b   Zucker, D ^a,c   Passamani, E ^a   Peduzzi, P ^d   Takaro, T ^d   Fisher, L D ^e   Kennedy, J W ^e   Davis, K ^e   Killip, T ^f   Norris, R ^g   Morris, C ^h   Mathur, V ⁱ   Varnauskas, E ^j   Chalmers, T C ^k  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d Department of Veterans   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g GREEN LANE HOSPITAL   (New Zealand)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ Division of Cardiovascular Anesthesiology Texas Heart Institute   (Canada)

^j UNIVERSITY OF GOTHENBURG   (Sweden)

^k TUFTS UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HUMAN; MALE; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; UNITED STATES;

ADULT; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SURVIVAL RATE; VENTRICULAR FUNCTION, LEFT;

EID: 0028017861     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)91963-1     Document Type: Article

References (20)

1. Saphenous vein autograft replacement of severe segmental coronary artery occlusions operative technique
2. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina
3. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study
4. CASS: a randomized trial of coronary bypass surgery
5. Coronary surgery after recurrent myocardial infarction: progress of a trial comparing surgical with nonsurgical management for asymptomatic patients with advanced coronary disease
6. Prospective randomized study of the surgical therapy of stable angina
7. Coronary bypass for stable angina
8. Beta blockade during and after myocardial infarction: an overview of the randomized trials
9. Regression modelling strategies for prognostic prediction
10. The standard error of an estimate of expectational life
11. Non parametric estimation from incomplete observations
12. Validation of a risk function to predict mortality in a VA population with coronary artery disease
13. The VA cooperative randomised study of surgery for coronary arterial occlusive disease II: the subgroup with significant left main lesions
14. The evolution of medical and surgical therapy for coronary artery disease: a 15 year perspective
15. Influence of the internal mammary artery on 10 year survival and other cardiac events
16. Secondary prevention of vascular disease by prolonged antiplatelet treatment
17. Observational comparison of event-free survival with medical and surgical therapy in patients with coronary artery disease: 20 years of follow up
18. Referral patterns for coronary artery disease treatment: gender bias or good clinical judgment?
19. Comparison of coronary artery bypass surgery and medical therapy in patients 65 years of age or older
20. Fifteen year follow-up of men and women with initial medical or surgical management for coronary artery disease